Opportunities and challenges for human papillomavirus vaccination in China-Reference-Cited by-同舟云学术

Opportunities and challenges for human papillomavirus vaccination in China

Published:2024-04-04 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zhao Chao¹,Zhao Yun¹,Li Jingran¹,Li Mingzhu¹,Shi Yujing²,Wei Lihui³^ORCID

Affiliation:

1. Gynaecology, Peking University People’s Hospital, Beijing, China

2. MRL Global Medical Affairs, MSD China, Shanghai, China

3. Department of Gynecology and Obstetrics, Peking University People’s Hospital

Funder

Medical writing support was funded by MSD China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2329450

Reference117 articles.

1. Human papillomavirus and cervical cancer

2. World Health Organization call for action to eliminate cervical cancer globally

3. Updates on HPV Vaccination

4. Centers for Disease Control and Prevention. Human Papillomavirus (HPV) vaccination: what everyone should know. 2021. https://www.cdc.gov/vaccines/vpd/hpv/public/index.html.

5. World Health Organization. List of prequalified vaccines. 2023. https://extranet.who.int/pqweb/vaccines/list-prequalified-vaccines.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

2. Mortality and disease burden of oral cancer in China: a time-trend analysis on the China Death Surveillance Database from 2006 to 2021;BMC Oral Health;2024-08-14

3. Exploring factors influencing awareness and knowledge of human papillomavirus in Chinese college students: A cross-sectional study;Human Vaccines & Immunotherapeutics;2024-08-14

4. HPV specificity and multiple infections and association with cervical cytology in Chongqing, China: a cross-sectional study;BMC Infectious Diseases;2024-08-09

5. Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective Study;Vaccines;2024-06-18